Titan Pharmaceuticals, Inc.: accounts_receivable
| Value | {"amount": 438000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2019-12-31) |
| Status | current |
| Entity | Titan Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:08:36.321546+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c30a71bd-4dba-4e93-9c51-ce4ab47aa621
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-21-044732 · Open the official SEC filing →Retrieved: 2026-08-19T09:08:36.321546+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000910267/accounts-receivable/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c30a71bd-4dba-4e93-9c51-ce4ab47aa621
History
- supersedes {"amount": 993000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} (evidence 0001104659-20-040354)